中药活性成分 — 姜黄素抗乳腺癌的基础研究新进展
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


New development of fundamental research on curcumin as active ingredients of traditional Chinese medicine in breast cancer therapy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    乳腺癌已成为中国女性最常罹患的恶性肿瘤,肿瘤绿色治疗已成为趋势,所以,研发“增效减毒”的抑制乳腺癌细胞增殖的药物对乳腺癌治疗具有十分重要的意义。姜黄素作为中草药姜黄根茎的活性提取物,因其有效抑制乳腺肿瘤细胞增殖,改善患者预后,有效减轻乳腺癌化疗后反应,正被越来越多的研究人员和临床医生青睐,成为研究的焦点。该文就姜黄素抑制乳腺癌增殖的分子机制,姜黄素剂型和载药系统,姜黄素联合放疗和化疗增效减毒的体内外实验研究进展进行综述。

    Abstract:

    Breast cancer has become one of the most frequently-occurred malignant tumors among Chinese women, while green therapy has turn into a new trend of tumor treatment. Therefore, exploration of new anti-cancer drugs has important significance for treatment of breast cancer. Curcumin, as an active ingredient of turmeric, was paid more attention by researchers and doctors, due to its inhibition of tumor cell proliferation, improving prognosis, reducing the reaction after chemotherapy. This article summarized the new research development of breast cancer cell’s proliferative inhibition mechanisms of drug delivery system of curcumin, function of synergy and attenuation of curcumin allying with chemotherapy and radiotherapy.

    参考文献
    相似文献
    引证文献
引用本文

吕艳,李翀,耿强.中药活性成分 — 姜黄素抗乳腺癌的基础研究新进展[J].中国现代医学杂志,2017,(28):41-44

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-12-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-12-10
  • 出版日期:
文章二维码